Form 4: Avid Bioservices Director Catherine Mackey Reports Stock Transactions
SEC Form 4 Filing
Director Catherine Mackey of Avid Bioservices, Inc. reports the vesting of restricted stock units and a new equity award grant.
Summary
- Catherine Mackey, a director at Avid Bioservices, Inc., reported transactions involving restricted stock units (RSUs).
- On December 14, 2024, 26,756 RSUs granted in 2023 vested, converting into common stock.
- Also on December 14, 2024, Mackey received an annual equity award grant of 8,147 RSUs.
- The newly granted RSUs will vest on December 14, 2025, contingent on continued service as a director.
Sentiment
Score: 7
Explanation: The document reflects standard equity transactions for a director, indicating a normal course of business. There is no indication of positive or negative sentiment.
Positives
- The vesting of RSUs indicates the fulfillment of previous equity compensation agreements.
- The new equity award grant suggests continued confidence in the director's role and the company's future.
Future Outlook
The newly granted RSUs will vest on December 14, 2025, contingent on the director's continued service.
Industry Context
This is a standard SEC Form 4 filing, reflecting routine equity transactions for a company director, which is common practice in publicly traded companies.
Comparison to Industry Standards
- Equity compensation, such as RSUs, is a common practice for directors in publicly traded companies like Avid Bioservices.
- The vesting schedule of one year for the initial grant and the subsequent grant is typical for director compensation packages.
- Companies like Catalent, Lonza, and Samsung Biologics also use similar equity-based compensation for their board members.
Stakeholder Impact
- The vesting of RSUs and the grant of new RSUs have a minor dilutive effect on existing shareholders.
- The transactions are part of the director's compensation and are not expected to have a significant impact on the company's operations or financial position.
Key Dates
| Date | Description |
|---|---|
| 12/14/2023 | Date of the grant of the 26,756 RSUs that vested on 12/14/2024 |
| 12/14/2024 | Date of vesting of 26,756 RSUs and grant of 8,147 new RSUs. |
| 12/14/2025 | Vesting date for the 8,147 RSUs granted on 12/14/2024. |
| 12/17/2024 | Date the form was signed. |
Keywords
Avid Bioservices, Director, Catherine Mackey, Restricted Stock Units, RSU, Equity Award, Vesting, Stock Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.